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Sperm cryopreservation allows patients with threatened fertility to preserve their reproductive potential.
A total of 41 patients who had their semen cryopreserved at Kansai Medical University Hospital from
January 2000 to March 2010 were enrolled in this study. For the first five years (2000-2005),
cryopreservation was performed free of charge, while in the last five years (2006-2010), patients were charged
for services and required to update their registration every 2 years. In addition, over the last five years,
subjects were limited to patients treated for their original disease at our institution. The mean age of the
patients was 27.7 years. The type of disease varied, and included testicular tumors (44%), hemotopoietic
organ tumors (44%), and other carcinomas (12%). All specimens cryopreserved during the first five years
continued to be cryopreserved without any prognostic investigation, except for one patient who had died.
For those patients required to update their registration, prognostic investigation was possible in all cases, and
one of the 6 patients updated their cryopreservation. In the case of the other five patients, abandonment
was due to recovery of spermatogenesis in 2 cases, death from original disease in 2 cases, and 1 case of
voluntary termination for reasons unknown. A paid and updated cryopreservation system may be useful for
the cryopreservation of sperm as a means of prognostic investigation.
(Hinyokika Kiyo 57 : 367-371, 2011)























































Table 1. Cryopreservation consent form
精子凍結保存説明書
(関西医科大学附属枚方病院泌尿器科)
私は，患者 様とその親族（患者が未成年 : 親権者，患者が成人で未婚 : 親族，患者が成人で既婚 : 配偶者）又は
代理者に対し，下記項目について説明いたしました．
内容を十分に理解し同意していただいた事項は以下のうち㋹をした項目です．































量 4.3 ml (1∼6 ml），精子濃度 27.8×106/ml (0.4∼
70×106/ml），運動率45.0％（10∼80％），造血器腫瘍
では精液量 3.4 ml (2.8∼5.6 ml），精子濃度 31.3×








ことになり，29例のうち死亡または lost to follow up と
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Fig. 1. Proportions of original disease as reason for
the cryopreservation of sperm.
泌57,07,04-2
Fig. 2. Outcomes of cryopreservation at Kansai
Medical University Takii Hospital.
なった患者が11名であった．疾患別では，精巣腫瘍患
者は16例中13例が生存を確認できたのに対し，造血器
腫瘍では 9 例中 4 例が死亡， 2 例が lost to follow up
で，生存を確認できたのは 3 例のみであった (Fig.
2）．附属枚方病院にて精子凍結保存を行った11例につ
いても，保存精子を融解し使用した症例はいまだな
















































































た8)． Meistrich らはアルキル化剤や，400∼600 mg/
m2 以上の白金製剤の投与は永続的な無精子症を来た
す可能性が高いと報告し9)，Howellらは精巣への放射
線の影響は 0.35∼0.5 Gy までは可逆的とされるが，
1.2 Gy 以上の照射で造精能は低下し，2.5 Gy 以上で
永続的な低下を引き起こすと報告している10)．Lampe
らは精巣腫瘍においてシスプラチンを使用した化学療
法後で造精機能の回復は 3∼ 5年で80％，Howell ら
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